Applied Genetic Technologies (AGTC) Tops Q1 EPS by 28c

Applied Genetic Technologies (NASDAQ: AGTC) reported Q1 EPS of $0.20, $0.28 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $11.8 million versus the consensus estimate of $10.21 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49